CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
The article focuses on the practical issues of selective revascularization of myocardium, including the specifics of procedure and patients characteristics, whom this intervention is at most indicated. The emphasis is done on antiplatelet therapy, its timing related to the procedure itself, and on t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2016-03-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/740 |
| _version_ | 1797856939227480064 |
|---|---|
| author | N. V. Teplova |
| author_facet | N. V. Teplova |
| author_sort | N. V. Teplova |
| collection | DOAJ |
| description | The article focuses on the practical issues of selective revascularization of myocardium, including the specifics of procedure and patients characteristics, whom this intervention is at most indicated. The emphasis is done on antiplatelet therapy, its timing related to the procedure itself, and on the recommended drugs. The data is provided from the point of evidence based medicine — recent European Guidelines. |
| first_indexed | 2024-04-09T20:48:40Z |
| format | Article |
| id | doaj.art-454438ad26084ef6a6721d892ef0bbf8 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:48:40Z |
| publishDate | 2016-03-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-454438ad26084ef6a6721d892ef0bbf82023-03-29T21:23:25Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202016-03-01039710010.15829/1560-4071-2016-3-97-100649CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATIONN. V. Teplova0N.I. Pirogov Russian National Research Medical UniversityThe article focuses on the practical issues of selective revascularization of myocardium, including the specifics of procedure and patients characteristics, whom this intervention is at most indicated. The emphasis is done on antiplatelet therapy, its timing related to the procedure itself, and on the recommended drugs. The data is provided from the point of evidence based medicine — recent European Guidelines.https://russjcardiol.elpub.ru/jour/article/view/740percutaneous coronary interventionaspirinacetylsalicylic acidclopidogrelclapitaxstable coronary heart diseaseangina |
| spellingShingle | N. V. Teplova CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION Российский кардиологический журнал percutaneous coronary intervention aspirin acetylsalicylic acid clopidogrel clapitax stable coronary heart disease angina |
| title | CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION |
| title_full | CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION |
| title_fullStr | CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION |
| title_full_unstemmed | CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION |
| title_short | CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION |
| title_sort | clopidogrel for selective myocardial revascularization |
| topic | percutaneous coronary intervention aspirin acetylsalicylic acid clopidogrel clapitax stable coronary heart disease angina |
| url | https://russjcardiol.elpub.ru/jour/article/view/740 |
| work_keys_str_mv | AT nvteplova clopidogrelforselectivemyocardialrevascularization |